Primegen Biotech LLC was founded in 2003 and is located at California. The company annual turnover is $1,600,000 with 16 employees having 10 years’ experience in Business. Primegen Biotech is dedicated to the research and therapeutic applications of adult stem cells, leading to individualized patient therapies.
The company has mainly focused on induced pluripotent stem cells (iPS cells), which has led to the breakthrough from research to therapy. Also the company has used carbon nanotubes in cell reprogramming that brings nanotube technology into field. Future applications will enlist patients own adult tissue cells to generate stem cells for regenerative and restorative medical treatments.
The following is the list of scholars from Primegen Biotech LLC who contributed and/or serves as editors for one or more OMICS International journals and conferences